Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 449

The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.

CD8+ T cells in the cancer-immunity cycle

Open access
Giles, Josephine R., Globig, Anna-Maria, Kaech, Susan M., Wherry, E. John·2023·Immunity

Abstract

CD8+ T cells are end effectors of cancer immunity. Most forms of effective cancer immunotherapy involve CD8+ T cell cytotoxic function. Here we review the current understanding of T cell function in cancer, focusing on key CD8+ T cell subtypes and states. We discuss factors that influence CD8+ T cell differentiation and function in cancer through a framework that incorporates the classic three signal model and a signal 4 – metabolism - and consider also the impact of the tumor microenvironment from a T cell perspective. We argue for the notion of immunotherapies as “pro-drugs” that act to augment or modulate T cells, which ultimately serve as the drug in vivo, and for the importance of overall immune health in cancer treatment and prevention. The progress in understanding T cell function in cancer will enable improved harnessing of the immune system across broader tumor types so as to benefit more patients. CD8+ T cells are “end effectors” of cancer immunity. Wherry, Kaech and colleagues review the current understanding of CD8+ T cell differentiation and function in cancer, discussing recent advance within a four-signal framework that incorporates T cell metabolism and the impact of the tumor microenvironment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2023.09.005

Cites

305 of 305 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 305 references

Cited by

See all 449

Metadata

Authors
Giles, J. R., Globig, A.-M., Kaech, S. M., & Wherry, E. J.
Venue
Immunity
Publisher
Elsevier BV
Published
2023-10
Volume
56
Issue
10
Pages
2231-2253
ISSN
1074-7613 (ISSN-L)
OpenAlex
W4387476832
Cited by
449
References
305
FWCI
46.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD8+ T cells in the cancer-immunity cycle. https://app.cochat.ai/papers/10.1016/j.immuni.2023.09.005
The paper
Giles, J. R., Globig, A.-M., Kaech, S. M., & Wherry, E. J. (2023). CD8+ T cells in the cancer-immunity cycle. Immunity. https://doi.org/10.1016/j.immuni.2023.09.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.